세계의 생체 적합성 3D 프린팅 재료 시장 : 시장 규모, 점유율, 동향 분석(제품별, 용도별, 지역별), 부문별 예측(2025-2030년)

Biocompatible 3D Printing Materials Market Size, Share & Trends Analysis Report By Type (Polymer, Metal), By Application (Implants & Prosthesis, Prototyping & Surgical Guides), By Region, and Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

시장 규모와 동향 :

세계의 생체 적합성 3D 프린팅 재료 시장 규모는 2024년에 6억 6,470만 달러로 추계되어 2025년부터 2030년까지 CAGR 14.6%를 나타낼 것으로 예측됩니다.

특수 생체 적합 재료 개발과 같은 3D 프린팅 기술의 발전으로 기능이 향상되고 인체와의 통합성이 향상된 환자 전용 장치를 만들 수 있습니다. 2024년 4월 Biomedicines의 연구는 심장 소작술의 수술 중 가이드를 위한 생체 적합성 3D 프린팅 재료의 안전성과 실현 가능성을 평가했습니다. 프로토타입은 멸균 후 양호한 기하학적 무결성을 보였으나, 절제 후 일부 샘플에서 질소와 황이 검출되어 추가 임상 연구의 필요성을 보여주었습니다.

의료 산업에서는 임플란트, 인공 장비, 조직 공학과 같은 의료 용도에 사용되는 생체 적합성 재료에 대한 수요가 증가하고 있습니다. 이러한 재료는 인체에 적합하도록 설계되어 거부 및 음성 반응의 가능성을 줄입니다. 이 수요는 3D 프린팅을 위한 고급 생체 적합성 재료의 개발을 뒷받침하고 있습니다. 2024년 6월, BIO INX는 DLP 기반의 3D (바이오)프린팅을 위해 설계된 형상 기억 기능을 갖춘 혁신적인 생분해성 수지인 DEGRES INX를 출시했습니다. 이 독특한 소재는 일시적으로 변형 될 수 있으며 체온까지 가열하면 원래 모양으로 돌아갑니다. 또한 ISO의 생체 적합성 기준을 충족하기 때문에 세포 배양에도 적합합니다.

최근의 3D 프린팅 기술 발전은 생체 적합성 재료 시장에 큰 영향을 미쳤습니다. 재료 및 인쇄 공정의 혁신으로 의료 용도에 안전하고 효과적인 옵션이 탄생했습니다. 2024년 10월, 스웨덴의 VBN Components는 내마모성 적층 성형 재료로 큰 발전을 이루었습니다. 이 회사의 Vibenite 포트폴리오는 코발트 크롬 사용과 관련된 안전성에 대한 우려가 높아지기 때문에 의료용 임플란트의 코발트 크롬을 대체하는 태세를 갖춘 혁신적인 합금을 특징으로 합니다.

맞춤형 의료의 대두가 생체 적합성 3D 프린팅 재료 시장을 더욱 뒷받침하고 있습니다. 이 접근법은 유전적 체질과 라이프 스타일 선택과 같은 개별 환자의 특성에 따라 맞춤형 치료를 제공하는 데 중점을 둡니다. 3D 프린팅 영역에서 개별화된 의료는 각 환자의 고유한 요구를 충족하도록 특별히 설계된 맞춤형 의료기기, 임플란트 및 의약품의 제작을 촉진합니다. Boston Micro Fabrication(BMF)은 2024년 10월, 회사의 microArch 시리즈 3D 프린터용으로, 특히 의료기기 분야를 타겟으로 한 4유형의 신재료를 발표했습니다. HTF 수지는 고온 내성, 생체 적합성, 유연성으로 두드러지며 멸균 및 재료 성능이 중요한 의료 용도에 이상적입니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 생체 적합성 3D 프린팅 재료 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 생체 적합성 3D 프린팅 재료 시장 : 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 생체 적합성 3D 프린팅 재료 시장 : 유형별 추정·동향 분석

• 생체 적합성 3D 프린팅 재료 시장 : 유형별 대시보드
• 생체 적합성 3D 프린팅 재료 시장 : 유형별 변동 분석
• 세계의 생체 적합성 3D 프린팅 재료 시장 : 유형별(수익 기준)
• 폴리머
• 금속
• 기타

제5장 생체 적합성 3D 프린팅 재료 시장 : 용도별 추정·동향 분석

• 생체 적합성 3D 프린팅 재료 시장 : 용도별 대시보드
• 생체 적합성 3D 프린팅 재료 시장 : 용도별 변동 분석
• 세계의 생체 적합성 3D 프린팅 재료 시장 : 용도별(수익 기준)
• 임플란트 및 보철물
• 프로토타이핑 및 수술 가이드
• 조직공학
• 보청기
• 기타

제6장 생체 적합성 3D 프린팅 재료 시장 : 지역별 추정·동향 분석(국가별, 유형별, 용도별)

• 지역 대시보드
• 시장 규모의 예측과 동향 분석(2018년·2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 최신 동향과 영향 분석 : 주요 제조업체별
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 유통업체·채널 파트너 목록
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2024년)
• 기업 프로파일
  • Formlabs Inc.
  • 3D Systems Inc.
  • Evonik Industries AG
  • Stratasys Ltd.
  • Concept Laser Gmbh
  • Renishaw plc
  • ENVISIONTEC US LLC
  • Cellink
  • DETAX Ettlingen
  • Hoganas AB

JHS

영문 목차

영문목차

Market Size & Trends:

The global biocompatible 3D printing materials market size was estimated at USD 664.7 million in 2024 and is projected to grow at a CAGR of 14.6% from 2025 to 2030. Advancements in 3D printing techniques, including developing specialized biocompatible materials, enable the creation of patient-specific devices with enhanced functionality and improved integration with the human body. In April 2024, a study in Biomedicines assessed the safety and feasibility of biocompatible 3D printing materials for intra-procedural guides in cardiac ablation. Prototypes showed good geometrical integrity post-sterilization, but traces of nitrogen and sulfur were found in some samples after ablation, indicating a need for additional clinical research.

The healthcare industry is experiencing a rising demand for biocompatible materials used in medical applications such as implants, prosthetics, and tissue engineering. These materials are designed to be compatible with the human body, reducing the likelihood of rejection or negative reactions. This demand is driving the development of advanced biocompatible materials for 3D printing. In June 2024, BIO INX launched DEGRES INX, an innovative biodegradable resin with shape memory capabilities designed for DLP-based 3D-(bio)printing. This unique material can be deformed temporarily and returns to its original shape when heated to body temperature. Furthermore, it meets ISO biocompatibility standards, making it suitable for cell cultivation.

Recent technological advancements in 3D printing have significantly influenced the market for biocompatible materials. Innovations in materials and printing processes have created safe and effective options for medical applications. In October 2024, VBN Components, a Swedish company, made significant advancements in wear-resistant additive manufacturing materials. Their Vibenite portfolio featured innovative alloys poised to replace cobalt chrome in medical implants due to increasing safety concerns associated with cobalt chrome usage.

The rise of personalized medicine is further propelling the biocompatible 3D printing materials market. This approach focuses on providing customized treatments based on individual patient characteristics, such as genetic makeup and lifestyle choices. In the realm of 3D printing, personalized medicine facilitates the creation of tailored medical devices, implants, and pharmaceuticals specifically designed to address the unique needs of each patient. In October 2024, Boston Micro Fabrication (BMF) introduced four new materials for its microArch series 3D printers, specifically targeting the medical device sector. The HTF resin stands out for its high-temperature resistance, biocompatibility, and flexibility, making it ideal for medical applications where sterilization and material performance are critical.

Global Biocompatible 3D Printing Materials Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global biocompatible 3D printing materials market report based on type, application, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Polymer
• Metal
• Others
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Implants & Prosthesis
• Prototyping & Surgical Guides
• Tissue Engineering
• Hearing Aids
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
• 2.3. Competitive Insights

Chapter 3. Biocompatible 3D Printing Materials Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand of biocompatible 3D printing materials in healthcare industry
    • 3.2.1.2. Technological advancements in 3D printing materials
    • 3.2.1.3. Growing adoption of personalized medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of biocompatible 3D printing materials
    • 3.2.2.2. Regulatory hurdles
• 3.3. Biocompatible 3D Printing Materials Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Biocompatible 3D Printing Materials Market: Type Estimates & Trend Analysis

• 4.1. Global Biocompatible 3D Printing Materials Market: Type Dashboard
• 4.2. Global Biocompatible 3D Printing Materials Market: Type Movement Analysis
• 4.3. Global Biocompatible 3D Printing Materials Market by Type, Revenue
• 4.4. Polymer
  • 4.4.1. Polymer market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Metal
  • 4.5.1. Metal market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.6. Others
  • 4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Biocompatible 3D Printing Materials Market: Application Estimates & Trend Analysis

• 5.1. Global Biocompatible 3D Printing Materials Market: Application Dashboard
• 5.2. Global Biocompatible 3D Printing Materials Market: Application Movement Analysis
• 5.3. Global Biocompatible 3D Printing Materials Market by Application, Revenue
• 5.4. Implants & Prosthesis
  • 5.4.1. Implants & Prosthesis market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Prototyping & Surgical Guides
  • 5.5.1. Prototyping & Surgical Guides market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Tissue Engineering
  • 5.6.1. Tissue Engineering market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.7. Hearing Aids
  • 5.7.1. Hearing aids market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Biocompatible 3D Printing Materials Market: Regional Estimates & Trend Analysis by Country, Type, and Application

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Formlabs Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. 3D Systems Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Evonik Industries AG
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Stratasys Ltd.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Concept Laser Gmbh
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Renishaw plc
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. ENVISIONTEC US LLC
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Cellink
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. DETAX Ettlingen
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Hoganas AB
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives

관련자료